Solesence, Inc
Price
FilingsNewest: 8-K, Material agreementOct 5 →Insiders1 insider bought $68,059 in 7 open-market buys. No sales.→HoldersVanguard 1.2%BlackRock 0.7%Bank of New York Mellon 0.4%→
From the filings
Figures
- Revenue
- $55.4Mlast 12 months
- Net income
- −$2.1Mlast 12 months
- Operating cash flow
- $171,000last 12 months
- Cash and equivalents
- $1.0Mat the last balance sheet
- Shares outstanding
- 70.6M shareson issue